copine 8 Inhibitors
Chemical inhibitors of copine 8 function by interfering with various cellular processes and signaling pathways that are essential for its activity. Alsterpaullone and roscovitine are compounds that target cyclin-dependent kinases (CDKs), which are crucial for the progression of the cell cycle. By inhibiting these kinases, these chemicals can prevent the proper functioning of copine 8 in cell signaling and proliferation, as copine 8 is thought to be involved in the regulation of cellular processes that are dependent on the cell cycle. Similarly, wortmannin and LY294002 inhibit phosphoinositide 3-kinases (PI3K), which play a significant role in cell growth and survival signaling pathways. The inhibition of PI3K can impede the activation and function of copine 8 by blocking the production of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), a critical second messenger in signaling pathways where copine 8 operates.
On another front, myoseverin disrupts the formation of microtubules, an integral component of the cell's cytoskeleton. As copine 8 is implicated in cytoskeleton-dependent processes, such as vesicle transport, the interference with microtubule dynamics can hamper copine 8's role in these processes. Protein kinase C (PKC) inhibitors like Go6983, GF109203X (bisindolylmaleimide I), chelerythrine, and bisindolylmaleimide IX also inhibit copine 8 by blocking PKC activity. Since copine 8 is associated with PKC-regulated pathways, these inhibitors can prevent its activation. Furthermore, staurosporine broadly inhibits protein kinases, affecting various kinase-dependent signaling pathways in which copine 8 may be involved, especially those related to cellular response to external signals. Lastly, U73122, a selective inhibitor of phospholipase C (PLC), can limit copine 8's function by inhibiting the production of secondary messengers like diacylglycerol (DAG) and inositol trisphosphate (IP3), which are vital for the signaling cascades that involve copine 8.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone is known to inhibit cyclin-dependent kinases (CDKs). Copine 8 is involved in signal transduction pathways that may be regulated by CDKs. Inhibition of CDKs can disrupt the cell cycle, which in turn could inhibit the function of copine 8 in cell signaling and proliferation. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is another CDK inhibitor, and by inhibiting these kinases, it can interfere with cell cycle progression. As copine 8 is thought to be involved in the regulation of cellular processes that are dependent on the cell cycle, roscovitine can inhibit the function of copine 8 by hindering these processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K). Copine 8, which plays a role in signal transduction pathways, may function downstream of PI3K signaling. Inhibition of PI3K can therefore inhibit the activation and function of copine 8 by preventing the generation of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which is crucial for the signaling pathways in which copine 8 is involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor, and it functions similarly to wortmannin. By inhibiting PI3K, LY294002 can inhibit the function of copine 8 in signal transduction, especially in pathways that depend on PI3K for activation and subsequent cellular responses that copine 8 may mediate. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go6983 is an inhibitor of protein kinase C (PKC). Since copine 8 has been associated with PKC-regulated pathways, inhibiting PKC can inhibit the function of copine 8 by preventing its activation or the activation of downstream molecules within signaling cascades that copine 8 is part of. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
GF109203X, also known as bisindolylmaleimide I, is another PKC inhibitor. By blocking PKC activity, GF109203X can inhibit the function of copine 8 by disrupting the signaling pathways that are regulated by PKC, which may be necessary for copine 8's role in cellular signaling and function. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a benzophenanthridine alkaloid that can inhibit PKC. The inhibition of PKC by chelerythrine can lead to the functional inhibition of copine 8 by hindering its role in PKC-dependent signaling pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of a wide range of protein kinases. It can inhibit the function of copine 8 by interfering with the kinase-dependent signaling pathways that copine 8 is involved in, particularly those related to cellular growth and response to extracellular signals. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
Bisindolylmaleimide IX is a selective inhibitor for PKC. Inhibition of PKC activity can lead to the functional inhibition of copine 8 by preventing its involvement in PKC-mediated signaling | ||||||